Skip to main content
TIGER-3: A Phase 3 Open-Label, Randomized Study of Rociletinib vs Chemotherapy in NSCLC Yang, J., Popat, S., Bazhenova, L., Blakely, C. M., Dichman, R., Felip, E., Griesinger, F., Groen, H. M., Gurubhagavatula, S., Leach, J. W., Novello, S., Perol, M., Patel, R., Reckamp, K., Georgiou, P., Miyamoto, E., Isaacson, J., Wakelee, H. A. ELSEVIER SCIENCE INC. 2015: S430

View details for Web of Science ID 000370365102086